Security key
810648105
scPharmaceuticals Inc. - Common Stock, par value $0.0001 per share (SCPH)
CUSIP: 810648105
Q2 2018 13F Holders as of 30 Jun 2018
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 53,364,241
- Total 13F shares
- 8,090,838
- Share change
- -226,630
- Total reported value
- $45,789,211
- Price per share
- $5.66
- Number of holders
- 37
- Value change
- -$6,149,684
- Number of buys
- 26
- Number of sells
- 13
Report period
Q2 2018
Institutions
37
Top holders
10
SCPH full security history
Newer quarter: Q3 2018
Previous quarter: Q1 2018
scPharmaceuticals Inc. SEC filings
scPharmaceuticals Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 810648105
Recent filing periods:
Top shareholders of SCPH - scPharmaceuticals Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC |
13F
|
Company |
6.4%
|
3,409,865
|
$42,282,000 | — | 31 Mar 2018 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
5.4%
|
2,857,143
|
$35,429,000 | — | 31 Mar 2018 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.57%
|
305,850
|
$3,793,000 | — | 31 Mar 2018 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.54%
|
288,469
|
$3,577,000 | — | 31 Mar 2018 | |
| Alyeska Investment Group, L.P. |
13F
|
Company |
0.42%
|
223,438
|
$2,771,000 | — | 31 Mar 2018 | |
| AWM Investment Company, Inc. |
13F
|
Company |
0.4%
|
213,317
|
$2,645,000 | — | 31 Mar 2018 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.38%
|
202,944
|
$2,516,000 | — | 31 Mar 2018 | |
| FMR LLC |
13F
|
Company |
0.37%
|
200,000
|
$2,480,000 | — | 31 Mar 2018 | |
| STATE STREET CORP |
13F
|
Company |
0.16%
|
86,680
|
$1,073,000 | — | 31 Mar 2018 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.13%
|
69,500
|
$862,000 | — | 31 Mar 2018 | |
| DAFNA Capital Management LLC |
13F
|
Company |
0.1%
|
55,844
|
$692,000 | — | 31 Mar 2018 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.09%
|
47,985
|
$595,000 | — | 31 Mar 2018 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.08%
|
43,935
|
$545,000 | — | 31 Mar 2018 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.08%
|
40,448
|
$501,000 | — | 31 Mar 2018 | |
| ESSEX INVESTMENT MANAGEMENT CO LLC |
13F
|
Company |
0.08%
|
40,373
|
$501,000 | — | 31 Mar 2018 | |
| CITIGROUP INC |
13F
|
Company |
0.07%
|
38,786
|
$481,000 | — | 31 Mar 2018 | |
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main |
13F
|
Company |
0.07%
|
36,206
|
$449,000 | — | 31 Mar 2018 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.06%
|
31,086
|
$385,000 | — | 31 Mar 2018 | |
| PRELUDE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.05%
|
24,330
|
$302,000 | — | 31 Mar 2018 | |
| MORGAN STANLEY |
13F
|
Company |
0.04%
|
23,260
|
$288,000 | — | 31 Mar 2018 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.03%
|
14,525
|
$180,000 | — | 31 Mar 2018 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.03%
|
13,400
|
$167,000 | — | 31 Mar 2018 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.03%
|
13,363
|
$166,000 | — | 31 Mar 2018 | |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM |
13F
|
Company |
0.02%
|
11,225
|
$139,000 | — | 31 Mar 2018 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.02%
|
9,460
|
$117,000 | — | 31 Mar 2018 | |
| AMERICAN INTERNATIONAL GROUP, INC. |
13F
|
Company |
0.01%
|
4,711
|
$58,000 | — | 31 Mar 2018 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.01%
|
4,264
|
$53,000 | — | 31 Mar 2018 | |
| STRS OHIO |
13F
|
Company |
0%
|
2,100
|
$26,000 | — | 31 Mar 2018 | |
| BARCLAYS PLC |
13F
|
Company |
0%
|
1,525
|
$19,000 | — | 31 Mar 2018 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
1,484
|
$18,000 | — | 31 Mar 2018 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0%
|
1,271
|
$15,760 | — | 31 Mar 2018 | |
| Legal & General Group Plc |
13F
|
Company |
0%
|
1,265
|
$16,000 | — | 31 Mar 2018 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0%
|
727
|
$9,000 | — | 31 Mar 2018 | |
| Ameritas Investment Partners, Inc. |
13F
|
Company |
0%
|
625
|
$8,000 | — | 31 Mar 2018 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
546
|
$7,000 | — | 31 Mar 2018 | |
| LADENBURG THALMANN FINANCIAL SERVICES INC. |
13F
|
Company |
0%
|
357
|
$4,000 | — | 31 Mar 2018 | |
| PNC FINANCIAL SERVICES GROUP, INC. |
13F
|
Company |
0%
|
118
|
$2,000 | — | 31 Mar 2018 | |
| PEDDOCK CAPITAL ADVISORS, LLC |
13F
|
Company |
0%
|
100
|
$1,000 | — | 31 Mar 2018 |
Institutional Holders of scPharmaceuticals Inc. - Common Stock, par value $0.0001 per share (SCPH) as of Q2 2018
As of 30 Jun 2018,
scPharmaceuticals Inc. - Common Stock, par value $0.0001 per share (SCPH) was held by
37 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
8,090,838 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, RA CAPITAL MANAGEMENT, LLC, AWM Investment Company, Inc., BlackRock Inc., Alyeska Investment Group, L.P., VANGUARD GROUP INC, STATE STREET CORP, MORGAN STANLEY, BRIDGEWAY CAPITAL MANAGEMENT INC, and NORTHERN TRUST CORP.
This page lists
37
institutional shareholders reporting positions in this security
for the Q2 2018 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2018 vs Q1 2018 Across Filers
Q1 2018 holders
37
Q2 2018 holders
37
Holder diff
0
| Investor | Q1 2018 Shares | Q2 2018 Shares | Share Diff | Share Chg % | Q1 2018 Value $ | Q2 2018 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.